Clinical Trial Update: Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study [Phase 2, Phase 3]

View source ↗

Summary

A randomized Phase 2/3 clinical trial evaluating nicotinamide and pyruvate for primary open-angle glaucoma is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Nicotinamide (nicotinamide)
• Pyruvate (Pyruvate)

Snippet

Sponsor: Columbia University | Conditions: Primary Open Angle Glaucoma | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING